Acadia Pharmaceuticals reported $-113056000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
ALKERMES ALKS:US $ -35.9M 36.78M
Alnylam Pharmaceuticals ALNY:US $ -240.34M 18.12M
Aptinyx Inc APTX:US $ -19827000 217K
Biogen BIIB:US $ 303.8M 64.4M
Biomarin Pharmaceutical BMRN:US $ 120.8M 178.7M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Cara Therapeutics CARA:US $ -27749000 5.63M
Corcept Therapeutics CORT:US $ 22.8M 9.26M
Cytokinetics CYTK:US $ -89.44M 58.88M
Eisai 4523:JP Y -12403M 26575M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
Johnson & Johnson JNJ:US $ 5149M 413M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Moderna Inc MRNA:US 3.66B 1.21B
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Pfizer PFE:US $ 7863M 4470M
Prothena PRTA:US $ -36.29M 3.11M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Seattle Genetics SGEN:US $ -136.49M 38.13M
Ultragenyx Pharmaceutical RARE:US $ -152.32M 29.86M
Vanda Pharmaceuticals VNDA:US $ -6.43M 13.51M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
YTE INCY:US $ 37.99M 525.86M